Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
Hyoscine butylbromide
Indication
Motion sickness, Nausea and vomiting, Vertigo, Gastrointestinal tract spasm, Genitourinary spasm, Preoperative medication,
Instruction
Administer via IM/IV/SC.
Drug interaction
May decrease the absorption of oral medicines due to decreased gastric motility and delayed gastric emptying. The sedative effect of hyoscine may be enhanced by other CNS depressants. Other drugs with anticholinergic properties (e.g. amantadine, antihistamines) may enhance the effects of hyoscine.
Malaysia
